의약품의 해부학적·치료학적 분류별 광고심의 5개년 현황과 광고의 질 개선을 위한 요인 분석

Abstract

There has been no study investigating which drug advertisements have recently increased or what decisions the Drug Advertisement Review Committee made based on the therapeutic classification of the drug. This study aimed to examine the status and trend of drug advertisement review by the Anatomical Therapeutic Chemical (ATC) Classification over the 5 years and identify factors that may increase the likelihood of receiving a decision other than ‘accepted’. We obtained drug advertise review data from the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (2017- 2021). The number of reviewed drugs and 5-year increase rate were calculated by ATC classification. We performed a logistic regression to compute odds ratios (ORs) for potential contributing factors. From 2017 to 2021, the overall reviewed drugs increased by 84.3%. The 5-year increase rate for ‘modification-needed’ (236.3%) and ‘inadequate’ (312.8%) decisions was higher than the overall 5-year increase rate. Drugs related to the Alimentary Tract and Metabolism underwent more advertisement reviews than those from other categories. Nearly all categories demonstrated an increasing trend in online media. Online media [OR=1.34; 95% confidence interval (CI), 1.27-1.42], drugs for Musculo-skeletal system (OR=1.13, 95% CI, 1.01-1.22) and sensory organs(OR, 1.82; 95% CI=1.58-2.08) were significantly increase the probability of receiving a decision other than ‘accepted’. Our results will be useful to improve drug advertisement review system and promote self-censorship of pharmaceutical companies.